Rising Healthcare Costs for Cancer Survivors: A Critical Overview

Marielle Santos McLeod, a cancer survivor from South Carolina, continues to face significant healthcare costs nearly four years after overcoming colon cancer. Following her 2017 diagnosis, she has managed ongoing expenses related to chemotherapy and subsequent monitoring, resulting in substantial out-of-pocket fees for regular specialist visits. Additionally, McLeod shoulders the cost of a family health insurance plan with a monthly premium of $895.

For McLeod, the financial burden necessitates difficult healthcare choices. She has delayed crucial medical procedures, such as a CT scan and a cardiology visit, due to costs despite severe symptoms. Her situation underscores the financial strain many cancer survivors face, often dealing with continuous medical debt. A 2024 survey from the American Cancer Society Cancer Action Network found that nearly half of cancer survivors held medical debt exceeding $5,000.

Impact of Health Insurance Plans on Survivors

Policy discussions have focused on high-deductible health plans promoted during the previous administration. While these plans aim to reduce monthly premiums, they may lead to significant upfront expenses before insurance coverage begins. Regulatory changes have also supported the expansion of health plans not compliant with the Affordable Care Act (ACA), granting insurers flexibility that could reduce coverage options for individuals with preexisting conditions.

The health insurance debate highlights the importance of adequate coverage for essential treatments. Particularly for cancer survivors, continuous care is critical. Some, like Jennifer Hoque from the American Cancer Society, assert that without ACA protections, insurance options for patients with prior diagnoses might diminish significantly.

Addressing Rising Healthcare Costs

Rising healthcare costs pose challenges for insurers balancing premium costs. Price hikes in pharmaceuticals and treatments have a broad impact. According to Brian Blase from Paragon Health Institute, underlying healthcare costs pose the largest challenge for cancer patients, often overshadowing specific insurance type considerations.

Efforts to lower drug prices may provide some relief. Programs under recent health legislation mandate price negotiations for expensive medications, potentially easing financial pressures on those needing ongoing treatment for conditions like cancer. Despite policy developments, the financial implications for survivors remain critical. As the population of cancer survivors grows, projected to exceed 22 million by 2035, addressing these financial challenges becomes increasingly important.